The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(ii)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
ALPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alpa Laboratories Ltd has filed a disclosure with BSE under Regulation 10(7) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. This pertains to an acquisition reported under Regulation 10(1)(a)(ii), which typically covers creeping acquisitions that are exempt from triggering a mandatory open offer to shareholders. The full details of the acquirer, number of shares, and pricing are not available in the provided headline, which appears truncated. This is a routine compliance disclosure under the takeover code framework.
For most retail shareholders, this is a routine regulatory filing with no immediate action needed. However, investors should watch for follow-up disclosures to understand who is buying and at what level, as creeping acquisitions can indicate a gradual build-up of stake that may eventually approach regulatory thresholds.